|
Stem cell (SC) yield and transplantation results from transplant-eligible newly diagnosed multiple myeloma (TE NDMM) patients (pts) receiving daratumumab (DARA) + bortezomib/thalidomide/dexamethasone (D-VTd) in the phase 3 CASSIOPEIA study. |
|
|
Honoraria - Abbvie; Amgen; Celgene; Janssen-Cilag; Takeda |
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen-Cilag |
|
|
Honoraria - Amgen; Celgene; Janssen-Cilag; Novartis; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Novartis; Takeda |
|
|
No Relationships to Disclose |
|
|
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests - Amgen; Celgene; Janssen; Takeda |
Consulting or Advisory Role - Amgen; Celgene; Janssen; Takeda |
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Novartis; Takeda |
|
|
No Relationships to Disclose |
|
|
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Takeda |
Speakers' Bureau - Celgene; Novartis; Takeda |
Travel, Accommodations, Expenses - Amgen; Celgene; Celgene |
|
|
Honoraria - Amgen; Takeda |
Consulting or Advisory Role - Amgen; Takeda |
Travel, Accommodations, Expenses - Amgen; Celgene; Takeda |
|
|
Honoraria - Amgen; Celgene |
Travel, Accommodations, Expenses - Amgen |
|
|
Travel, Accommodations, Expenses - Celgene; Janssen |
|
|
|
Consulting or Advisory Role - Amgen; Takeda |
Travel, Accommodations, Expenses - Amgen; Janssen |
|
|
No Relationships to Disclose |
|
|
|
Consulting or Advisory Role - Celgene |
|
|
Research Funding - Leo Pharma; Pfizer |
|
|
No Relationships to Disclose |
|
|
Employment - Janssen Research & Development |
Stock and Other Ownership Interests - Janssen Research & Development |
|
|
Employment - Janssen Biotech |
|
|
|
|
|
|
Stock and Other Ownership Interests - Janssen |
|
|
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis; SERVIER |
Speakers' Bureau - Amgen; Bristol-Myers Squibb; Celgene; Janssen Research & Development |
Research Funding - Amgen; Bristol-Myers Squibb; Celgene; Janssen; Novartis |